Structures by: Jones W.
Total: 266
Triamterene, succinic acid and DMSO
C12H12N71,C4H5O41,C2H6OS
IUCrJ (2018) 5, 3
a=13.5226(7)Å b=14.9966(7)Å c=10.6958(5)Å
α=90° β=104.179(2)° γ=90°
Triamterene, acetic acid and DMSO
C12H12N71,C2H6OS,C2H3O21
IUCrJ (2018) 5, 3
a=10.8022(2)Å b=13.9084(2)Å c=14.6076(3)Å
α=115.2840(10)° β=109.088(2)° γ=90.5250(10)°
Triamterene, adipic acid and DMSO
2(C12H12N7),C6H8O4,2(C2H6OS)
IUCrJ (2018) 5, 3
a=11.0286(3)Å b=13.7429(4)Å c=14.9742(5)Å
α=115.247(2)° β=109.951(4)° γ=90.122(2)°
Triamterene, azelaic acid and DMSO
2(C12H12N71),C9H14O42,2(C2H6OS)
IUCrJ (2018) 5, 3
a=15.0338(3)Å b=11.5004(2)Å c=24.3960(6)Å
α=90° β=104.5390(10)° γ=90°
Triamterene, pimelic acid and DMSO
2(C12H12N71),C7H10O42,2(C2H6OS)
IUCrJ (2018) 5, 3
a=14.0750(5)Å b=14.8889(6)Å c=19.635(2)Å
α=86.408(2)° β=88.142(3)° γ=71.702(2)°
Triamterene, nicotinic acid and DMSO
C12H12N71,C12H11N7,C6H4NO21,2(C2H6OS)
IUCrJ (2018) 5, 3
a=14.8461(2)Å b=12.3081(3)Å c=21.2850(5)Å
α=90° β=105.1760(10)° γ=90°
Triamterene and Ibuprofen salt, DMSO solvate
C12H12N71,C12H11N7,C13H17O21,C2H6OS
IUCrJ (2018) 5, 3
a=11.2398(3)Å b=13.2439(3)Å c=15.4624(4)Å
α=113.595(2)° β=103.527(3)° γ=91.977(2)°
Triamterene
C12H11N7
Chemistry Central Journal (2017) 63, 11
a=7.4432(15)Å b=9.993(2)Å c=16.648(3)Å
α=77.55(2)° β=87.54(3)° γ=87.09(3)°
C8H10N4O2,C7H4F2O2
C8H10N4O2,C7H4F2O2
Chemical Science (2013) 4, 12 4417
a=11.39598(91)Å b=9.15968(51)Å c=15.8701(12)Å
α=90° β=104.0247(43)° γ=90°
C8H10N4O2,C7H6O2
C8H10N4O2,C7H6O2
Chemical Science (2013) 4, 12 4417
a=11.2358(13)Å b=9.1056(10)Å c=15.9131(18)Å
α=90° β=104.5787(42)° γ=90°
C8H10N4O2,C7H4F2O2
C8H10N4O2,C7H4F2O2
Chemical Science (2013) 4, 12 4417
a=11.36104(82)Å b=9.11522(46)Å c=15.8828(13)Å
α=90° β=101.7770(41)° γ=90°
C8H10N4O2,C7H4F2O2
C8H10N4O2,C7H4F2O2
Chemical Science (2013) 4, 12 4417
a=11.33562(74)Å b=9.12362(42)Å c=15.9442(11)Å
α=90° β=104.2599(39)° γ=90°
C8H10N4O2,C7H2F4O2
C8H10N4O2,C7H2F4O2
Chemical Science (2013) 4, 12 4417
a=14.2630(11)Å b=8.13716(48)Å c=16.0129(16)Å
α=90° β=121.2142(35)° γ=90°
C8H10N4O2,C7H5F1O2
C8H10N4O2,C7H5F1O2
Chemical Science (2013) 4, 12 4417
a=11.30697(76)Å b=9.06586(42)Å c=15.94455(91)Å
α=90° β=105.2800(33)° γ=90°
C8H10N4O2,C7H5F1O2
C8H10N4O2,C7H5F1O2
Chemical Science (2013) 4, 12 4417
a=8.78113(87)Å b=10.06607(56)Å c=10.5609(14)Å
α=105.8710(58)° β=72.7172(63)° γ=71.1516(63)°
Theobromine trifluoroacetic acid
C7H8N4O2,C2HF3O2
Organic letters (2007) 9, 16 3133-3136
a=5.09253(14)Å b=8.33537(37)Å c=14.89683(42)Å
α=90.1645(18)° β=95.5873(17)° γ=99.7283(22)°
Theobromine malonic acid
C7H8N4O2,C3H4O4
Organic letters (2007) 9, 16 3133-3136
a=12.44248(60)Å b=12.90355(55)Å c=7.67255(26)Å
α=90° β=91.2464(23)° γ=90°
2
C13H18N4O10
Molecular Pharmaceutics (2007) 4, 3 347
a=17.9217(2)Å b=6.17660(10)Å c=15.3751(3)Å
α=90.00° β=105.2120(10)° γ=90.00°
3
(C8H10N4O2),(C6H8O7)
Molecular Pharmaceutics (2007) 4, 3 347
a=7.38740(10)Å b=8.3967(2)Å c=13.5053(3)Å
α=91.3330(10)° β=99.0400(10)° γ=99.5880(10)°
CTA/An
C9H12O6,C2H3N1
New Journal of Chemistry (2003) 27, 2 365
a=6.8309(5)Å b=16.0470(13)Å c=22.8001(11)Å
α=90.00° β=90.00° γ=90.00°
CTA/APY
C4H5N3,C9H12O6
New Journal of Chemistry (2003) 27, 2 365
a=5.6250(2)Å b=23.8851(18)Å c=11.2217(9)Å
α=90.00° β=100.109(5)° γ=90.00°
CTA/oPh/2MeOH
C9H12O6,C12H8N2,C2H8O2
New Journal of Chemistry (2003) 27, 2 365
a=8.8501(5)Å b=11.0316(8)Å c=11.8635(7)Å
α=90.185(3)° β=95.174(4)° γ=92.475(4)°
CTA/HMTA
C9H12O6,C6H12N4
New Journal of Chemistry (2003) 27, 2 365
a=10.9547(4)Å b=14.4867(6)Å c=10.4289(4)Å
α=90.00° β=93.987(2)° γ=90.00°
Iodopentafluorobenzene-phenazine 1/1
C6F5I,C12H8N2
New Journal of Chemistry (2008) 32, 10 1776
a=16.8943(3)Å b=7.22990(10)Å c=14.9051(2)Å
α=90.00° β=116.0800(10)° γ=90.00°
Iodopentafluorobenzene-acridine 1/1
C6F5I,C13H9N
New Journal of Chemistry (2008) 32, 10 1776
a=16.9525(3)Å b=7.2187(2)Å c=14.9464(3)Å
α=90.00° β=116.2460(10)° γ=90.00°
Acridine-bromopentafluorobenzene 1/1
C6BrF5,C13H9N
New Journal of Chemistry (2008) 32, 10 1776
a=17.0193(7)Å b=7.2045(2)Å c=14.7399(3)Å
α=90.00° β=116.5350(10)° γ=90.00°
2(C7H8N4O2),3(C4H7NO)
2(C7H8N4O2),3(C4H7NO)
CrystEngComm (2019) 21, 13 2097
a=7.5056(3)Å b=25.0862(9)Å c=15.2376(6)Å
α=90° β=93.195(2)° γ=90°
C7H8N4O2,C4H7NO
C7H8N4O2,C4H7NO
CrystEngComm (2019) 21, 13 2097
a=6.6482(3)Å b=8.7311(4)Å c=10.9852(5)Å
α=82.631(2)° β=84.273(2)° γ=83.701(3)°
Fumaric acid:Pyrazine cocrystal
C4H4O4,C4H4N2
CrystEngComm (2012) 14, 16 5203
a=5.1006(7)Å b=6.1168(8)Å c=6.9894(10)Å
α=85.396(11)° β=82.199(12)° γ=85.176(11)°
Pyrazine:phtalic acid cocrystal
C8H6O4,C4H4N2
CrystEngComm (2012) 14, 16 5203
a=6.93440(24)Å b=13.59704(73)Å c=14.51054(72)Å
α=90° β=122.2085(29)° γ=90°
C4H6O4,C4H4N2
C4H6O4,C4H4N2
CrystEngComm (2012) 14, 16 5203
a=8.5311(4)Å b=5.1286(2)Å c=10.2947(5)Å
α=90.00° β=103.012(5)° γ=90.00°
Pyrazine:terephthalic acid cocrystal
C8H6O4,C4H4N2
CrystEngComm (2012) 14, 16 5203
a=3.81056(10)Å b=7.07204(32)Å c=11.50344(44)Å
α=94.9505(15)° β=93.5324(20)° γ=115.2753(18)°
2,3 lutidine pamoate
2(C7H10N),C23H14O6
CrystEngComm (2009) 11, 2 254-260
a=15.197(3)Å b=13.262(3)Å c=15.716(3)Å
α=90.00° β=107.20(3)° γ=90.00°
2,4 lutidine pamoate
C23H14O6,2(C7H10N)
CrystEngComm (2009) 11, 2 254-260
a=8.2989(17)Å b=11.453(2)Å c=16.924(3)Å
α=72.76(3)° β=85.65(3)° γ=77.85(3)°
3,4 lutidine pamoate
C23H14O6,2(C7H10N)
CrystEngComm (2009) 11, 2 254-260
a=11.196(2)Å b=12.653(3)Å c=22.963(5)Å
α=104.32(3)° β=103.24(3)° γ=91.58(3)°
Nicotinamide:malonic acid 2/1
2(C6H6N2O),C3H4O4
CrystEngComm (2009) 11, 3 470
a=32.9054(6)Å b=4.0078(1)Å c=12.3689(2)Å
α=90.00° β=90.00° γ=90.00°
Nictinamide:fumaric acid 1:1
C6H6N2O,C4H4O4
CrystEngComm (2009) 11, 3 470
a=5.53140(10)Å b=13.7844(4)Å c=14.2056(5)Å
α=90.00° β=92.5900(10)° γ=90.00°
Nicotinamide:glutaric acid 1:1
C6H6N2O,C5H8O4
CrystEngComm (2009) 11, 3 470
a=5.4556(5)Å b=7.3692(6)Å c=15.1945(13)Å
α=99.413(5)° β=94.592(5)° γ=104.775(3)°
Nicotinamide:azelaic acid 2:1
C6H6N2O,C9H16O4
CrystEngComm (2009) 11, 3 470
a=8.64550(10)Å b=36.5695(6)Å c=5.20210(10)Å
α=90.00° β=90.00° γ=90.00°
Nicotinamide:adipic acid 1:1
C6H10O4,C6H6N2O
CrystEngComm (2009) 11, 3 470
a=5.0110(1)Å b=5.3379(1)Å c=24.0348(6)Å
α=93.036(1)° β=92.753(1)° γ=92.189(1)°
Nicotinamide:adipic acid 2:1
C6H10O4,2(C6H6N2O)
CrystEngComm (2009) 11, 3 470
a=5.0302(3)Å b=5.4600(3)Å c=16.9903(9)Å
α=82.380(4)° β=89.395(4)° γ=90.006(2)°
Nicotinamide:suberic acid 2:1
C8H14O4,2(C6H6N2O)
CrystEngComm (2009) 11, 3 470
a=5.0288(3)Å b=5.4403(3)Å c=18.7537(11)Å
α=93.062(3)° β=94.810(3)° γ=90.740(2)°
Nicotinamide:sebacic acid 2:1
C10H18O4,2(C6H6O2N)
CrystEngComm (2009) 11, 3 470
a=5.0365(2)Å b=5.4470(2)Å c=20.5004(9)Å
α=89.354(2)° β=84.241(2)° γ=89.872(2)°
2,6 lutidine succinic acid co-crystal
2(C7H9N),C4H6O4
CrystEngComm (2006) 8, 11 830
a=15.733(3)Å b=15.106(3)Å c=7.6047(15)Å
α=90.00° β=98.56(3)° γ=90.00°
2,3 lutidine fumarate
C7H10N,C4H3O4,C4H4O4
CrystEngComm (2006) 8, 11 830
a=9.0541(18)Å b=18.159(4)Å c=9.7343(19)Å
α=90.00° β=91.20(3)° γ=90.00°
2,3 lutidine fumaric acid co-crystal
C14H18N2,C4H4O4
CrystEngComm (2006) 8, 11 830
a=9.8746(4)Å b=7.1925(4)Å c=12.2559(5)Å
α=90.00° β=96.810(3)° γ=90.00°
2,4 lutidine fumarate
C7H10N1,0.5(C4H2O41),0.5(C4H4O4)
CrystEngComm (2006) 8, 11 830
a=3.96530(10)Å b=13.7652(4)Å c=20.0488(6)Å
α=90.00° β=91.6030(10)° γ=90.00°
2,3 lutidine succinic acid co-crystal
2(C7H9N),C4H6O4
CrystEngComm (2006) 8, 11 830
a=10.0598(3)Å b=7.3023(3)Å c=12.2512(4)Å
α=90.00° β=97.470(2)° γ=90.00°
2,4 lutidine succinic acid co-crystal
2(C7H9N),C4H6O4
CrystEngComm (2006) 8, 11 830
a=4.8672(10)Å b=12.763(3)Å c=14.374(3)Å
α=90.00° β=96.20(3)° γ=90.00°
2,5 lutidine fumarate
C7H10N1,C4H4O4,0.5(C4H2O42)
CrystEngComm (2006) 8, 11 830
a=7.2696(2)Å b=9.1353(3)Å c=11.6311(3)Å
α=84.115(2)° β=72.513(2)° γ=88.763(2)°
2,5 lutidine succinic acid co-crystal
2(C7H9N),C4H6O4
CrystEngComm (2006) 8, 11 830
a=4.7197(9)Å b=15.272(3)Å c=12.819(3)Å
α=90.00° β=97.38(3)° γ=90.00°
3,4 lutidine fumarate
C7H10N1,0.5(C4H2O42),C4H4O4
CrystEngComm (2006) 8, 11 830
a=7.0478(2)Å b=10.0870(3)Å c=10.8570(3)Å
α=102.305(2)° β=104.584(2)° γ=107.975(2)°
3,4 lutidine succinic acid co-crystal
2(C7H9N),C4H6O4
CrystEngComm (2006) 8, 11 830
a=9.802(2)Å b=6.0385(12)Å c=15.626(3)Å
α=90.00° β=102.49(3)° γ=90.00°
3,5 lutidine fumaric acid co-crystal
2(C7H9N),C4H4O4
CrystEngComm (2006) 8, 11 830
a=8.2345(16)Å b=16.299(3)Å c=6.9681(14)Å
α=90.00° β=108.17(3)° γ=90.00°
3,5 lutidine succinic acid co-crystal
2(C7H9N),C4H6O4
CrystEngComm (2006) 8, 11 830
a=10.464(2)Å b=4.9696(10)Å c=17.113(3)Å
α=90.00° β=95.67(3)° γ=90.00°
Zn(PT)1.2(MTT)0.8(H2O)
(C5H4NOS1)1.2,(C4H4NOS21)0.8,(Zn2),(H2O)
Journal of Materials Chemistry (2002) 12, 2 324
a=7.1353(5)Å b=11.6238(5)Å c=15.9011(12)Å
α=90.00° β=90.00° γ=90.00°
Phenazine mesaconic acid
C12H8N2,C5H6O4
Journal of Materials Chemistry (2000) 10, 4 839
a=26.833(26)Å b=7.095(4)Å c=19.613(27)Å
α=90.00° β=127.46(7)° γ=90.00°
Phenazine bis(maleic acid)
C12H8N2,2(C4H4O4)
Journal of Materials Chemistry (2000) 10, 4 839
a=5.513(2)Å b=6.733(2)Å c=13.026(7)Å
α=95.32(3)° β=99.39(4)° γ=100.24(3)°
Phenazine fumaric acid
C12H8N2,C4H4O4
Journal of Materials Chemistry (2000) 10, 4 839
a=5.3361(6)Å b=8.7650(8)Å c=14.9520(10)Å
α=90.00° β=98.871(8)° γ=90.00°
Phenazine bis (citraconic acid)
C12H8N2,2(C5H6O4)
Journal of Materials Chemistry (2000) 10, 4 839
a=6.6790(9)Å b=18.660(2)Å c=8.9330(10)Å
α=90.00° β=105.13(2)° γ=90.00°
Phenazine succinic acid
C12H8N2,C4H6O4
Journal of Materials Chemistry (2000) 10, 4 839
a=5.2792(4)Å b=9.0570(10)Å c=15.0540(10)Å
α=90.00° β=99.141(7)° γ=90.00°
Phenazine bis(glutaric acid)
C12H8N2,2(C5H8O4)
Journal of Materials Chemistry (2000) 10, 4 839
a=5.6755(5)Å b=9.997(2)Å c=10.8660(10)Å
α=116.611(10)° β=95.117(11)° γ=90.044(10)°
Methyldiphenylphosphine:1,4-diiodotetrafluorobenzene 2/1
2(C13H13PO)(C6F4I2)
CrystEngComm (2012) 14, 19 6110
a=5.74470(10)Å b=16.4119(2)Å c=32.2290(5)Å
α=90.00° β=90.00° γ=90.00°
Methyldiphenylphosphine oxide
C13H13OP,C6F4I2
CrystEngComm (2012) 14, 19 6110
a=9.4440(3)Å b=10.8391(4)Å c=11.7728(4)Å
α=111.084(2)° β=110.207(2)° γ=97.956(2)°
1,4-diiodotetrafluorobenzene
C6F4I2
CrystEngComm (2012) 14, 19 6110
a=6.2187(3)Å b=11.6168(7)Å c=5.7876(5)Å
α=90.00° β=93.61(3)° γ=90.00°
(mdppo)2(ofib)
2(C13H13OP),C4F8I2
CrystEngComm (2012) 14, 19 6110
a=11.5465(2)Å b=5.8340(1)Å c=24.7421(5)Å
α=90.00° β=91.269(1)° γ=90.00°
Lamotrigine hemiadipate n-butyl acetate solvate
2(C9H8Cl2N5),C6H8O4,C6H12O2
CrystEngComm (2013) 15, 7 1332
a=12.6675(4)Å b=12.9716(4)Å c=13.7656(5)Å
α=107.3580(10)° β=114.6190(10)° γ=103.1370(10)°
Lamotrigine hemiadipate tetrahydrofuran solvate
2(C9H8Cl2N5),C6H8O4,2(C4H8O)
CrystEngComm (2013) 15, 7 1332
a=12.6839(2)Å b=13.1519(2)Å c=13.6466(2)Å
α=107.0840(10)° β=114.3670(10)° γ=101.9840(10)°
Lamotrigine hemipimelate tetrahydrofuran solvate
2(C9H8Cl2N5),C7H10O4,2(C4H8O)
CrystEngComm (2013) 15, 7 1332
a=12.9830(3)Å b=13.6706(3)Å c=13.8425(4)Å
α=102.6810(10)° β=115.7560(10)° γ=106.841(2)°
Lamotrigine hemipimelate n-butyl acetate solvate
2(C9H8Cl2N5),C7H10O4,C6H12O2
CrystEngComm (2013) 15, 7 1332
a=12.5864(3)Å b=13.5421(3)Å c=13.9251(4)Å
α=104.191(2)° β=114.809(2)° γ=105.476(2)°
1a
2(C8H8O3)2(C6H6N2O)
Faraday Discussions (2007) 136, 167
a=32.6557(9)Å b=5.4751(10)Å c=14.9264(5)Å
α=90.00° β=99.4000(10)° γ=90.00°
C8H7ClNO3
C8H7ClNO3
CrystEngComm (2006) 8, 7 545
a=3.7440(10)Å b=6.0320(10)Å c=18.631(2)Å
α=97.660(10)° β=92.280(10)° γ=90.470(10)°
C24H30Cl2N2O6
C24H30Cl2N2O6
CrystEngComm (2006) 8, 7 545
a=5.0843(3)Å b=8.3131(5)Å c=15.9637(8)Å
α=77.760(3)° β=89.771(3)° γ=74.353(3)°
C18H20N2O6
C18H20N2O6
CrystEngComm (2006) 8, 7 545
a=9.2224(4)Å b=10.0926(5)Å c=10.0772(5)Å
α=90.00° β=113.116(3)° γ=90.00°
C26H36N2O6
C26H36N2O6
CrystEngComm (2006) 8, 7 545
a=36.856(2)Å b=5.1674(2)Å c=29.4327(18)Å
α=90.00° β=112.806(2)° γ=90.00°
1,4-DIIODOTETRAFLUOROBENZENE - 1,4-DITHIANE 2/1
2(C6F4I2),(C4H8S2)
CrystEngComm (2011) 13, 9 3224
a=6.3597(2)Å b=8.6865(2)Å c=11.2216(3)Å
α=69.182(1)° β=89.501(1)° γ=81.866(1)°
Acridine:tetrafluoro-1,2-diiodobenzene 7/4
7(C13H9N1)4(C6F4I2)
CrystEngComm (2011) 13, 9 3224
a=9.3792(1)Å b=13.2620(2)Å c=20.9590(4)Å
α=74.809(1)° β=88.358(1)° γ=78.396(1)°
Phenazine:tetrafluoro-1,2-diiodobenzene 1/1
(C12H8N2)(C6F4I2)
CrystEngComm (2011) 13, 9 3224
a=14.3077(3)Å b=7.6892(2)Å c=20.0916(4)Å
α=90.00° β=125.881(1)° γ=90.00°
Triphenylphosphine oxide:1,4-diiodotetrafluorobenzene 1:1
(C18H16PO)(C6F4I2)
CrystEngComm (2011) 13, 9 3224
a=15.8642(2)Å b=8.3329(1)Å c=18.4437(3)Å
α=90.00° β=106.542(1)° γ=90.00°
C15H12N2O,C2H6OS
C15H12N2O,C2H6OS
Physical chemistry chemical physics : PCCP (2011) 13, 28 12808-12816
a=7.4105(3)Å b=8.9753(3)Å c=12.2407(4)Å
α=94.259(2)° β=94.526(3)° γ=100.200(2)°
C15H12N2O,C2H6OS
C15H12N2O,C2H6OS
Physical chemistry chemical physics : PCCP (2011) 13, 28 12808-12816
a=7.3605(2)Å b=8.9292(3)Å c=12.2136(3)Å
α=94.491(2)° β=94.715(2)° γ=100.070(2)°
C15H12N2O,C2H6OS
C15H12N2O,C2H6OS
Physical chemistry chemical physics : PCCP (2011) 13, 28 12808-12816
a=7.3605(2)Å b=8.9292(3)Å c=12.2136(3)Å
α=94.491(2)° β=94.715(2)° γ=100.070(2)°
C15H12N2O,C2H6OS
C15H12N2O,C2H6OS
Physical chemistry chemical physics : PCCP (2011) 13, 28 12808-12816
a=8.8708(2)Å b=12.1901(3)Å c=14.6128(4)Å
α=94.9700(10)° β=100.2170(10)° γ=95.0360(10)°
C15H12N2O2,C2H6OS
C15H12N2O2,C2H6OS
Physical chemistry chemical physics : PCCP (2011) 13, 28 12808-12816
a=10.6987(2)Å b=12.4986(3)Å c=11.9748(3)Å
α=90.00° β=91.0670(10)° γ=90.00°
Trimethoprim+2-aminoterephthalic acid
2(C14H18N4O3),C8H7N1O4
CrystEngComm (2011) 13, 21 6315
a=9.19770(10)Å b=8.25530(10)Å c=23.7783(4)Å
α=90.00° β=96.1930(10)° γ=90.00°
Coumarin-3-carboxylic acid+4,4'-bipyridylethene
C12H10N2,2(C10H6O4)
CrystEngComm (2012) 14, 16 5121
a=16.2227(4)Å b=5.02570(10)Å c=16.3150(5)Å
α=90.00° β=100.9180(10)° γ=90.00°
Coumarin-3-carboxylic acid+4,4'-bipyridine
2(C10H6O4),C10H8N2
CrystEngComm (2012) 14, 16 5121
a=3.90990(10)Å b=20.2636(3)Å c=15.3093(3)Å
α=90.00° β=91.3460(10)° γ=90.00°
Coumarin-3-carboxylic acid+4,4'-bipyridylethane
C12H12N2,2(C10H6O4)
CrystEngComm (2012) 14, 16 5121
a=16.3933(6)Å b=4.8921(2)Å c=16.5326(8)Å
α=90.00° β=103.209(2)° γ=90.00°
Coumarin-3-carboxylic acid+pyridine-2,6-diamine
C10H5O4,C5H8N3
CrystEngComm (2012) 14, 16 5121
a=13.8797(2)Å b=12.9776(5)Å c=7.3847(6)Å
α=90.00° β=90.383(2)° γ=90.00°
C7H5NO4,C4H7NO
C7H5NO4,C4H7NO
CrystEngComm (2012) 14, 7 2552
a=5.8384(2)Å b=9.1212(3)Å c=22.1209(7)Å
α=90.00° β=94.571(2)° γ=90.00°
C7H4N2O6,C4H7NO
C7H4N2O6,C4H7NO
CrystEngComm (2012) 14, 7 2552
a=11.4528(5)Å b=6.3801(3)Å c=17.643(1)Å
α=90.00° β=90.489(2)° γ=90.00°
C8H5F3O2,C5H9NO
C8H5F3O2,C5H9NO
CrystEngComm (2012) 14, 7 2552
a=10.8821(4)Å b=7.6597(3)Å c=16.4743(6)Å
α=90.00° β=103.612(3)° γ=90.00°
C7H6O4,C4H5NO2
C7H6O4,C4H5NO2
CrystEngComm (2012) 14, 7 2552
a=6.5358(2)Å b=7.6095(3)Å c=11.8452(4)Å
α=79.803(2)° β=78.578(2)° γ=75.337(2)°
C7H4N2O6,C5H9NO
C7H4N2O6,C5H9NO
CrystEngComm (2012) 14, 7 2552
a=7.4022(1)Å b=13.3198(3)Å c=15.1641(3)Å
α=109.418(1)° β=93.784(1)° γ=104.670(1)°
Pyrimethaminium+saccharinate+methanol
C12H14ClN41,C7H4NO3S1,CH4O
CrystEngComm (2013) 15, 15 2916
a=6.90400(10)Å b=7.58660(10)Å c=21.2823(3)Å
α=85.3640(10)° β=81.0520(10)° γ=79.0070(10)°
Pyrimethamine+theophylline
C12H13ClN4,C7H8N4O2
CrystEngComm (2013) 15, 15 2916
a=7.9789(4)Å b=10.3092(5)Å c=13.6586(7)Å
α=68.186(3)° β=87.884(2)° γ=75.726(3)°
Pyrimethaminium+aspirinate+acetonitrile
C12H14ClN41,C9H7O41,C2H3N
CrystEngComm (2013) 15, 15 2916
a=10.0012(3)Å b=11.5494(4)Å c=11.7171(4)Å
α=107.432(2)° β=106.355(2)° γ=99.557(2)°
Pyrimethaminium+alpha-ketoglutarate
C12H14ClN41,C5H5O51
CrystEngComm (2013) 15, 15 2916
a=7.8393(2)Å b=11.0472(3)Å c=12.1060(4)Å
α=82.881(2)° β=71.670(2)° γ=69.719(2)°
Pyrimethaminium+p-coumarate+water
C12H14ClN41,C9H7O31,H2O
CrystEngComm (2013) 15, 15 2916
a=7.60860(10)Å b=9.9450(2)Å c=14.6138(3)Å
α=80.9630(10)° β=87.2240(10)° γ=72.8160(10)°
C12H8N2,C5H6O4
C12H8N2,C5H6O4
CrystEngComm (2013) 15, 1 175
a=16.5230(1)Å b=15.9952(3)Å c=5.4792(3)Å
α=90.00° β=90.00° γ=90.00°